1994
DOI: 10.1097/00002820-199410000-00001
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy; A comparison with the fatigue experienced by healthy individuals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
206
0
18

Year Published

1997
1997
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 361 publications
(243 citation statements)
references
References 0 publications
15
206
0
18
Order By: Relevance
“…1,16,38 Estimates of cancer-related fatigue during initial treatment range from approximately 60% to 90%, 2,39-42 with the highest reported frequency in patients undergoing chemotherapy (80% to 96%) 40,43 compared with those treated with radiation (60% to 93%). 16,39,44 For example, in the study by Andrykowski et al, patients undergoing adjuvant chemotherapy were more than two-times as likely to report cancer-related fatigue during treatment compared with patients who were receiving adjuvant radiation therapy. 26 Bower has suggested that a key mechanism in the fatigue experienced during adjuvant radiation treatment may be the activation of proinflammatory cytokines.…”
Section: Fatigue During Treatmentmentioning
confidence: 99%
“…1,16,38 Estimates of cancer-related fatigue during initial treatment range from approximately 60% to 90%, 2,39-42 with the highest reported frequency in patients undergoing chemotherapy (80% to 96%) 40,43 compared with those treated with radiation (60% to 93%). 16,39,44 For example, in the study by Andrykowski et al, patients undergoing adjuvant chemotherapy were more than two-times as likely to report cancer-related fatigue during treatment compared with patients who were receiving adjuvant radiation therapy. 26 Bower has suggested that a key mechanism in the fatigue experienced during adjuvant radiation treatment may be the activation of proinflammatory cytokines.…”
Section: Fatigue During Treatmentmentioning
confidence: 99%
“…Depending on the patient sample and methodology employed, it is estimated that approximately 60 -96% of cancer patients who are undergoing cancer treatments experience fatigue (Cella, 1998). Fatigue is extremely common among cancer patients undergoing cytotoxic chemotherapy, radiation therapy, bone marrow transplant or treatment with biological response modifiers (Irvine et al, 1994;Dean et al, 1995;Hann et al, 1999;Jacobsen et al, 1999). For a significant number of patients, fatigue persists after treatment is completed.…”
Section: Prevalence Of Cancer-related Fatiguementioning
confidence: 99%
“…[9][10][11][12] In an early cross-sectional investigation, Wolcott et al 13 (1986) evaluated the physical symptomatology of young adult ABMT patients (n = 26), assessed at a mean of 42 months post-treatment. Approximately 25% reported frequent, ongoing physical symptoms including diarrhea, dry mouth and abdominal cramps, and one-third described having a high number of infections within the past year.…”
Section: Physical Symptomatology and Fatiguementioning
confidence: 99%
“…[9][10][11][15][16][17][18][19] For BMT patients, fatigue appears to be an especially significant and impairing problem. For example, a cross-sectional, descriptive study, conducted by Whedon et al 20 (1995), indicated that among 29 patients assessed, fatigue was the most frequently reported symptom, with 50% endorsing moderate to severe levels as many as 3 or more years after autologous transplant.…”
Section: Physical Symptomatology and Fatiguementioning
confidence: 99%